The purpose of this study is to: 1. Compare the pharmacokinetics profiles of pregabalin sustained release tablet (300mg) to immediate release capsule(150mg \* 2). 2. Evaluate the effectiveness of food to pharmacokinetics profile of Pregabalin sustained release tablet.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
sustained release formulation of pregabalin
Cmax, AUC of pregabalin
Time frame: 0~36h
Safety evaluation
Time frame: 0~24day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.